截至9月30日，开开实业股东户数3.37万，较上期减少7.03%；人均流通股0股，较上期增加0.00%。2025 年1月-9月，开开实业实现营业收入8.25亿元，同比增长10.76%；归母净利润1286.78万元，同比减少 62.81%。 责任编辑：小浪快报 分红方面，开开实业A股上市后累计派现1.91亿元。近三年，累计派现3474.90万元。 开开实业今年以来股价跌9.66%，近5个交易日跌2.49%，近20日涨1.63%，近60日跌1.22%。 今年以来开开实业已经1次登上龙虎榜，最近一次登上龙虎榜为1月2日，当日龙虎榜净买入-1120.05万 元；买入总计5518.17万元 ，占总成交额比8.51%；卖出总计6638.22万元 ，占总成交额比10.24%。 资料显示，上海开开实业股份有限公司位于上海市静安区昌平路678号一楼，成立日期1997年8月4日， 上市日期2001年2月28日，公司主营业务涉及以中医药流通、中医药学服务(中医问诊服务)和服装批 发、零售为主营业务。主营业务收入构成为：批发类74.48%，零售类18.18%，卫生服务类4.42%，租赁 类1.77%，其他1.14%。 机构持仓方面， ...

Market Overview - The medical consumables supply chain SPD sector experienced a decline of 1.42% on November 19, with Ailong Technology leading the drop [1] - The Shanghai Composite Index closed at 3946.74, up 0.18%, while the Shenzhen Component Index closed at 13080.09, unchanged [1] Stock Performance - Key stocks in the medical consumables supply chain SPD sector showed mixed performance, with Jianfa Zhixin rising by 3.19% to a closing price of 34.00, while several others, including Guoyao Yici and Jiuzhoutong, saw declines of 0.55% and 0.59% respectively [1] - The trading volume and turnover for Jianfa Zhixin were 180,800 hands and 620 million yuan, respectively [1] Capital Flow - The medical consumables supply chain SPD sector saw a net outflow of 99.05 million yuan from main funds, while retail investors contributed a net inflow of 74.72 million yuan [2] - Notable individual stock capital flows included Jianfa Zhixin with a net inflow of 70.39 million yuan from main funds, while Ailong Technology experienced a net outflow of 2.99 million yuan [3]

今年以来开开实业已经1次登上龙虎榜，最近一次登上龙虎榜为1月2日，当日龙虎榜净买入-1120.05万 元；买入总计5518.17万元 ，占总成交额比8.51%；卖出总计6638.22万元 ，占总成交额比10.24%。 资料显示，上海开开实业股份有限公司位于上海市静安区昌平路678号一楼，成立日期1997年8月4日， 上市日期2001年2月28日，公司主营业务涉及以中医药流通、中医药学服务(中医问诊服务)和服装批 发、零售为主营业务。主营业务收入构成为：批发类74.48%，零售类18.18%，卫生服务类4.42%，租赁 类1.77%，其他1.14%。 开开实业所属申万行业为：医药生物-医药商业-医药流通。所属概念板块包括：SPD概念、民营医院、 医药电商、小盘、中药等。 11月19日，开开实业盘中下跌2.01%，截至10:48，报14.11元/股，成交1.02亿元，换手率4.46%，总市值 37.06亿元。 资金流向方面，主力资金净流出433.08万元，特大单买入113.11万元，占比1.11%，卖出0.00元，占比 0.00%；大单买入1198.49万元，占比11.72%，卖出1744.68万元，占比17.0 ...

Market Overview - The pharmaceutical commercial sector experienced a decline of 0.92% on November 18, with Yao Yigou leading the drop [1] - The Shanghai Composite Index closed at 3939.81, down 0.81%, while the Shenzhen Component Index closed at 13080.49, down 0.92% [1] Stock Performance - Notable gainers included: - Ren Da Medical (603108) with a closing price of 15.97, up 2.90% and a trading volume of 278,200 shares, totaling 442 million yuan [1] - People's Tongtai (600829) with a closing price of 17.72, up 6.49% and a trading volume of 1,148,700 shares, totaling 1.902 billion yuan [1] - Major decliners included: - Yao Yigou (300937) with a closing price of 33.95, down 6.37% and a trading volume of 115,000 shares, totaling 396 million yuan [2] - Luhua Pharmaceutical (002788) with a closing price of 10.29, down 5.86% and a trading volume of 467,300 shares, totaling 489 million yuan [2] Capital Flow - The pharmaceutical commercial sector saw a net outflow of 706 million yuan from institutional investors, while retail investors contributed a net inflow of 705 million yuan [2] - The overall capital flow indicates a mixed sentiment, with institutional investors withdrawing while retail investors remained active [2] Individual Stock Capital Flow - Ren Da Medical (603108) had a net inflow of 49.2 million yuan from institutional investors, while retail investors saw a net outflow of 65.5 million yuan [3] - Yao Yigou (300937) experienced a significant net outflow of 560.4 million yuan from institutional investors [3] - The data reflects varying levels of investor confidence across different stocks within the sector [3]

Market Overview - The medical consumables supply chain SPD sector experienced a decline of 1.51% on November 17, with the leading stock, Kaikai Industrial, falling significantly [1] - The Shanghai Composite Index closed at 3972.03, down 0.46%, while the Shenzhen Component Index closed at 13202.0, down 0.11% [1] Stock Performance - Notable gainers in the SPD sector included: - Langma Information: closed at 14.57, up 1.75% with a trading volume of 69,100 shares and a turnover of 100 million yuan - Dashi Intelligent: closed at 3.04, up 1.00% with a trading volume of 527,100 shares and a turnover of 160 million yuan - Guoxin Health: closed at 10.05, up 0.60% with a trading volume of 103,900 shares and a turnover of 104 million yuan [1] - Major decliners included: - Kaikai Industrial: closed at 14.83, down 4.14% with a trading volume of 312,500 shares and a turnover of 463 million yuan - Jianfa Zhixin: closed at 34.76, down 3.44% with a trading volume of 137,400 shares and a turnover of 481 million yuan - Yingte Group: closed at 11.85, down 2.79% with a trading volume of 87,300 shares and a turnover of 104 million yuan [2] Capital Flow - The SPD sector saw a net outflow of 244 million yuan from institutional investors, while retail investors contributed a net inflow of 241 million yuan [2] - The detailed capital flow for selected stocks showed: - Guokai Hengtai: net inflow of 7.31 million yuan from institutional investors - Dashi Intelligent: net outflow of 8.11 million yuan from retail investors - Langma Information: net outflow of 1.80 million yuan from retail investors [3]

Market Overview - The primary economic sector experienced a slight decline of 0.04% compared to the previous trading day, with *ST Yazhen leading the drop [1] - The Shanghai Composite Index closed at 3972.03, down 0.46%, while the Shenzhen Component Index closed at 13202.0, down 0.11% [1] Stock Performance - Notable gainers included: - Miao Exhibition (300795) with a closing price of 14.60, up 3.55% on a trading volume of 97,800 shares and a turnover of 144 million [1] - Remote Technology (002291) closed at 7.06, up 3.37% with a trading volume of 540,900 shares and a turnover of 376 million [1] - Major decliners included: - *ST Yazhen (603389) closed at 45.89, down 4.99% with a trading volume of 32,300 shares and a turnover of 149 million [2] - Kai Kai Industry (600272) closed at 14.83, down 4.14% with a trading volume of 312,500 shares and a turnover of 46.3 million [2] Capital Flow - The primary economic sector saw a net outflow of 113 million from main funds, while speculative funds had a net inflow of 37.65 million, and retail investors saw a net inflow of 75.09 million [2] - Specific stock capital flows indicated: - Miao Exhibition had a main fund net inflow of 21.1 million, while retail investors experienced a net outflow of 22.96 million [3] - Remote Technology had a main fund net inflow of 13.22 million, with retail investors seeing a net outflow of 19.80 million [3]

Market Overview - The pharmaceutical commercial sector experienced a decline of 1.62% on November 17, with Luyuan Pharmaceutical leading the drop [1] - The Shanghai Composite Index closed at 3972.03, down 0.46%, while the Shenzhen Component Index closed at 13202.0, down 0.11% [1] Stock Performance - Notable gainers included: - Renmin Tongtai (600829) with a closing price of 16.64, up 9.98% and a trading volume of 768,000 shares, totaling 1.276 billion yuan [1] - Other stocks in the sector showed mixed results, with several companies like Shanghai Pharmaceuticals (601607) and Guoyao Yizhi (000028) experiencing declines of 1.20% and 1.53% respectively [1] Capital Flow - The pharmaceutical commercial sector saw a net outflow of 875 million yuan from institutional investors, while retail investors contributed a net inflow of 674 million yuan [2] - The data indicates that retail investors were more active in the market compared to institutional investors during this period [2] Individual Stock Capital Flow - Key stocks with significant capital flow include: - Shuyuan Pingmin (301017) with a net inflow of 17.85 million yuan from institutional investors, while retail investors had a net outflow of 35.94 million yuan [3] - Nanjing Pharmaceutical (600713) had a net inflow of 17.30 million yuan from institutional investors, but also saw outflows from retail investors [3] - Guoyao Yizhi (000028) and Shanghai Pharmaceuticals (601607) also experienced mixed capital flows, with institutional inflows but retail outflows [3]

Core Viewpoint - The pharmaceutical commercial sector is experiencing a significant downturn, with multiple companies facing declines in stock prices [2] Company Performance - Yiyigou has seen a drop of over 7% in its stock price [2] - Other companies such as Shuyupingmin, Kaikai Industry, Jiashitang, and Yifeng Pharmacy are also experiencing declines [2]

证券代码：600272 900943 证券简称：开开实业 开开B股 公告编号：2025-071 上海开开实业股份有限公司 关于召开2025年第一次临时股东大会的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 股东大会召开日期：2025年11月21日 ● 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票系统 上海开开实业股份有限公司（以下简称："公司"）于2025年10月29日召开第十届董事会第二十九次会 议，审议通过了《关于召开2025年第一次临时股东大会的通知》，公司定于2025年11月21日召开2025年 第一次临时股东大会，并已于2025年10月31日在《上海证券报》《香港商报》和上海证券交易所网站 （www.sse.com.cn）上刊登了《关于召开2025年第一次临时股东大会的通知》。为进一步保护投资者的 合法权益，为公司股东行使股东大会表决权提供便利，现将有关事项再次提示如下： 一、召开会议的基本情况 （一）股东大会类型和届次 （四）现场会议召开的日期、时间和地点 召开的 ...

Market Performance - As of November 14, the pharmaceutical e-commerce sector rose by 1.24%, ranking 9th among concept sectors, with 93 stocks increasing in value [1] - Notable gainers included Shuyuan Pharmaceutical and Kangzhi Pharmaceutical, both reaching a 20% limit up, while Jiaying Pharmaceutical and People's Tongtai also hit the limit up [1] - The top gainers in the sector included Jinshiyao, Minsheng Health, and Jiashitang, which rose by 8.10%, 7.62%, and 5.97% respectively [1] Capital Inflow - The pharmaceutical e-commerce sector saw a net inflow of 1.058 billion yuan, with 70 stocks receiving net inflows, and 5 stocks exceeding 100 million yuan in net inflow [2] - The leading stock in terms of net inflow was Zhongsheng Pharmaceutical, with a net inflow of 732 million yuan, followed by Te Yi Pharmaceutical and Kangzhi Pharmaceutical with net inflows of 299 million yuan and 258 million yuan respectively [2] Stock Performance - The stocks with the highest net inflow ratios included ST Zhongzhu, Shuyuan Pharmaceutical, and Zhongsheng Pharmaceutical, with net inflow ratios of 42.18%, 37.31%, and 36.05% respectively [3] - Notable stock performances included Zhongsheng Pharmaceutical and Te Yi Pharmaceutical both achieving a 9.98% increase, while Kangzhi Pharmaceutical reached a 20% increase [3][4] Additional Insights - The pharmaceutical e-commerce sector's performance was supported by significant capital inflows, indicating strong investor interest [2][3] - The overall market sentiment appears positive for the pharmaceutical e-commerce sector, as evidenced by the number of stocks hitting the upper limit and the substantial net inflows [1][2]